Edesa Biotech, Inc. Common Shares logo

EDSA Earnings Date: Dec 11, 2026 (Estimated) — Edesa Biotech, Inc. Common Shares

XNAS · Healthcare · Biotechnology

Updated

Price $2.70
Market Cap $26.0M
P/E —
52W Range $0.72 – $20.32
Next Earnings · After close (est.)

When is EDSA's next earnings date?

Edesa Biotech, Inc. Common Shares (EDSA) is expected to report Q4 2026 earnings on Friday, December 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.56.

How did EDSA do in its last earnings report?

In its most recent report on Aug 13, 2026 (Q3 2026), Edesa Biotech, Inc. Common Shares posted EPS of -$0.60 versus the -$0.43 estimate, a miss of 36.4%. Revenue was $0. The stock's 1-day post-earnings move was -1.5%.

How much does EDSA stock move after earnings?

EDSA beat EPS estimates in 3 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 5.4% (up or down) in the day after earnings.

About Edesa Biotech, Inc. Common Shares

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-13Q3 2026-0.43-0.60-36.36%$0❌ Miss-1.47%-12.34%-23.85%
2026-05-14Q2 2026-0.26-0.49-88.46%$0❌ Miss-10.68%-25.60%-59.34%
2026-02-13Q1 2026-0.38-0.28+26.32%$0✅ Beat+0.49%-11.86%+586.27%
2025-12-12Q4 2025-0.27-0.32-18.52%$0❌ Miss-16.09%-14.94%-16.67%
2025-08-08Q3 2025-0.25-0.25+0.00%$0➖ Inline-0.47%+5.42%+14.62%
2025-02-14Q1 2025—-0.48—$0—-7.06%-16.73%-11.52%
2024-12-13Q4 2024-0.54-0.29+46.30%$0✅ Beat-1.86%-10.65%-12.71%
2024-08-09Q3 2024-0.58-0.52+10.34%$0✅ Beat-4.75%-9.50%-7.44%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .